Works matching DE "PHARMACEUTICAL research

Results: 3951

FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 814
Publication type:: Article

Announcements.

Published in:: Oncology (08909091), 2009, v. 23, n. 9, p. 743
Publication type:: Article

Priority Review Granted for Peginterferon Alfa-2b to Treat Stage III Melanoma.

Published in:: Oncology (08909091), 2008, v. 22, n. 2, p. 204
Publication type:: Article

Examining the determinants of drug launch delay in pre-TRIPS India.

Published in:

European Journal of Health Economics, 2013, v. 14, n. 5, p. 761, doi. 10.1007/s10198-012-0422-7

By:

Bhaduri, Saradindu;
Brenner, Thomas

Publication type:

Article

The desirability and feasibility of economic studies of drugs post-launch.

Published in:

2006

By:

Drummond, Michael;
Mason, Anne;
Towse, Adrian

Publication type:

Editorial

Aripiprozole-Induced Diplopia: A Case Report.

Published in:

Klinik Psikofarmakoloji Bulteni, 2013, v. 23, n. 4, p. 353, doi. 10.5455/bcp.20130303114826

By:

Atli, Abdullah;
Selvi, Yavuz;
Yildiz, Aydın;
Kaya, Mehmet Cemal

Publication type:

Article

İnterferon Tedavisi Alan ve Almayan Hepatit C Hastalarında Anksiyete ve Depresyon Düzeyleri.

Published in:

Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 3, p. 155

By:

Yumru, Mehmet;
Sırmatel, Fatma;
Vırıt, Osman;
Savaş, Esen;
Savaş, Haluk A.;
Herken, Hasan

Publication type:

Article

Liverpool Üniversitesi Antipsikotiklerin Yan Etkilerini Değerlendirme Ölçeği'nin Türkçe Formunun Güvenilirliği.

Published in:

Klinik Psikofarmakoloji Bulteni, 2006, v. 16, n. 3, p. 147

By:

Yilmaz, Sevil;
Sevim Buzlu

Publication type:

Article

Anti-infectives: Targeting SARS.

Published in:

Nature Reviews Microbiology, 2004, v. 2, n. 9, p. 686, doi. 10.1038/nrmicro985

By:

Jones, Susan

Publication type:

Article

Innovation: Seeing is believing: the impact of structural genomics on antimicrobial drug discovery.

Published in:

Nature Reviews Microbiology, 2004, v. 2, n. 9, p. 739, doi. 10.1038/nrmicro978

By:

Schmid, Molly B.

Publication type:

Article

Antivirals and antiviral strategies.

Published in:

Nature Reviews Microbiology, 2004, v. 2, n. 9, p. 704, doi. 10.1038/nrmicro975

By:

Clercq, Erik De

Publication type:

Article

Developing ANDI: a novel approach to health product R&D in Africa.

Published in:

2010

By:

Nwaka, Solomon;
Ilunga, Tshinko B.;
Da Silva, Jorge Santos;
Verde, Emiliano Rial;
Hackley, Doan;
De Vré, Raymond;
Mboya-Okeyo, Tom;
Ridley, Robert G.;
Rial Verde, Emiliano;
De Vré, Raymond

Publication type:

journal article

New Approaches to Filling the Gap in Tuberculosis Drug Discovery.

Published in:

PLoS Medicine, 2007, v. 4, n. 11, p. e293, doi. 10.1371/journal.pmed.0040293

By:

Casenghi, Martina;
Cole, Stewart T.;
Nathan, Carl F.

Publication type:

Article

Development of New Tuberculosis Vaccines: A Global Perspective on Regulatory Issues.

Published in:

PLoS Medicine, 2007, v. 4, n. 8, p. e252, doi. 10.1371/journal.pmed.0040252

By:

Brennan, Michael J.;
Fruth, Uli;
Milstien, Julie;
Tiernan, Rosemary;
Nishioka, Sergio De Andrade;
Chocarro, Liliana

Publication type:

Article

Industry-Sponsored Research: Author's Reply.

Published in:

2006

By:

Sotelo, Julio

Publication type:

Letter

Industry-Sponsored Research: A More Comprehensive Alternative.

Published in:

2006

By:

Mansfield, Peter

Publication type:

Letter

Cholinesterase inhibitors: drugs looking for a disease?

Published in:

2006

By:

Maggini, Marina;
Vanacore, Nicola;
Raschetti, Roberto

Publication type:

journal article

Correction: A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need.

Published in:

2005

By:

Moran, Mary

Publication type:

Correction Notice

New Drugs for Neglected Diseases: From Pipeline to Patients.

Published in:

PLoS Medicine, 2004, v. 1, n. 1, p. 019, doi. 10.1371/journal.pmed.0010006

By:

Pécoul, Bernard

Publication type:

Article

Development of Problem Sets for K-12 and Engineering on PHARMACEUTICAL PARTICULATE SYSTEMS.

Published in:

CEE: Chemical Engineering Education, 2010, v. 44, n. 1, p. 50

By:

SAVELSKI, MARIANO J.;
SLATER, C. STEWART;
DEL VECCHIO, CHRISTOPHER A.;
KOSTELESKI, ADRIAN J.;
WILSON, SARAH A.

Publication type:

Article

Non-fungible tokens as a framework for sustainable innovation in pharmaceutical R&D: a smart contract-based platform for data sharing and rightsholder protection.

Published in:

International Review of Law, Computers & Technology, 2024, v. 38, n. 1, p. 66, doi. 10.1080/13600869.2023.2233803

By:

Compagnucci, Marcelo Corrales;
Nilsson, Niclas;
Wagner, Paul Stankovski;
Olsson, Christoffer;
Fenwick, Mark;
Minssen, Timo;
Szkalej, Kacper

Publication type:

Article

Biopharma R&D Partnerships: From David & Goliath to Networked R&D.

Published in:

R&D Management, 2017, v. 47, n. 2, p. 330, doi. 10.1111/radm.12248

By:

Ensing, Erik

Publication type:

Article

The evaluation of risk in pharmaceutical research: a study of current models and techniques.

Published in:

R&D Management, 2016, v. 46, n. 5, p. 900, doi. 10.1111/radm.12200

By:

Oreskovich, Anne‐Marie;
Gittins, John

Publication type:

Article

Implementing Lean Sigma in pharmaceutical research and development: a review by practitioners.

Published in:

R&D Management, 2009, v. 39, n. 1, p. 95, doi. 10.1111/j.1467-9310.2008.00542.x

By:

Carleysmith, Stephen W.;
Dufton, Ann M.;
Altria, Kevin D.

Publication type:

Article

Successful pharmaceutical discovery: Paul Janssen's concept of drug research.

Published in:

R&D Management, 2007, v. 37, n. 4, p. 355, doi. 10.1111/j.1467-9310.2007.00481.x

By:

Lewi, Paul J.;
Smith, Adam

Publication type:

Article

Evaluating growth options as sources of value for pharmaceutical research projects.

Published in:

R&D Management, 2001, v. 31, n. 2, doi. 10.1111/1467-9310.00212

By:

Loch, Christoph H.;
Bode‐Greuel, Kerstin

Publication type:

Article

Why crash pharmaceutical research?

Published in:

R&D Management, 1997, v. 27, n. 1, p. 79, doi. 10.1111/1467-9310.00043

By:

Gittins, John

Publication type:

Article

The allocation of resources for R&D in the world's leading pharmaceutical companies.

Published in:

R&D Management, 1997, v. 27, n. 1, p. 63, doi. 10.1111/1467-9310.00042

By:

Halliday, Richard G.;
Drasdo, Alison L.

Publication type:

Article

Stigmergy, Anyone?

Published in:

Bio-IT World, 2011, v. 10, n. 5, p. 14

By:

BUSH, ERNIE

Publication type:

Article

Briefs.

Published in:: Bio-IT World, 2011, v. 10, n. 5, p. 10
Publication type:: Article

3-D is Cool, but Is It Useful to Drug Development?

Published in:

Bio-IT World, 2011, v. 10, n. 3, p. 14

By:

Bush, Ernie

Publication type:

Article

Taking the High Road.

Published in:

Bio-IT World, 2010, v. 9, n. 4, p. 20

By:

POH, ALISSA

Publication type:

Article

A New Rap for Chemistry.

Published in:

Bio-IT World, 2010, v. 9, n. 3, p. 45

By:

DAVIES, KEVIN

Publication type:

Article

A Medical Decision Support System That Learns.

Published in:

Bio-IT World, 2009, v. 8, n. 4, p. 30

By:

PROFFITT, ALLISON

Publication type:

Article

Agile IT Strategy in Pharmaceutical R&D.

Published in:

Bio-IT World, 2009, v. 8, n. 2, p. 20

By:

CHADWICK, ANDREW

Publication type:

Article

Pacific Rim Warms Up to EDC.

Published in:

Bio-IT World, 2008, v. 7, n. 8, p. 29

By:

NEUER, ANN

Publication type:

Article

Bottlenecks in Drug Discovery.

Published in:

Bio-IT World, 2008, v. 7, n. 8, p. 28

By:

KLEIN, FRANK

Publication type:

Article

The Recruitment Problem.

Published in:

2008

By:

BORFITZ, DEBORAH

Publication type:

Proceeding

Art Exhibit Highlights Drug Safety.

Published in:: 2007
Publication type:: Art Exhibition Review

Focusing Drug Computation on Fragments.

Published in:

Bio-IT World, 2007, v. 6, n. 6, p. 26

By:

May, Mike

Publication type:

Article

New Products.

Published in:: 2006
Publication type:: Product Review

The Advantages of a Drug Safety Commons.

Published in:

Bio-IT World, 2006, v. 5, n. 8, p. 16

By:

Neumann, Eric K.

Publication type:

Article

Drug Discovery As Easy As Pie.

Published in:

Bio-IT World, 2006, v. 5, n. 4, p. 36

By:

May, Mike

Publication type:

Article

Optimizing Optimata.

Published in:

Bio-IT World, 2005, v. 4, n. 11, p. 46

By:

Russell, John

Publication type:

Article

Bridges and Boundaries in Drug Discovery Research.

Published in:

Bio-IT World, 2005, v. 4, n. 11, p. 30

By:

Davies, Kevin

Publication type:

Article

Coming Attractions.

Published in:

Bio-IT World, 2005, v. 4, n. 3, p. 6

By:

Davies, Kevin

Publication type:

Article

Return of the Network Data Model.

Published in:

Bio-IT World, 2004, v. 3, n. 9, p. S-20

By:

Kupfer, Ken

Publication type:

Article

HPC: One Size Does Not Fit All.

Published in:

Bio-IT World, 2004, v. 3, n. 9, p. S-8

By:

Stevens, Daniel

Publication type:

Article

The True Cost of Drug Discovery.

Published in:

Bio-IT World, 2004, v. 3, n. 7, p. 4

By:

Davies, Kevin

Publication type:

Article

Pfizer's Man with the R&D Plan.

Published in:: 2003
Publication type:: Interview